NCT04303039View on ClinicalTrials.gov

Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 22, 2020

Primary Completion Date

June 9, 2020

Study Completion Date

June 19, 2020

Conditions
GoutFood-drug Interaction
Interventions
DRUG

ABP-671

ABP-671 Tablet 1.0 mg

Trial Locations (1)

21201

Pharmaron CPC, Inc., Baltimore

Sponsors
All Listed Sponsors
lead

Atom Therapeutics Co., Ltd

INDUSTRY

NCT04303039 - Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter